Affordable Access

Publisher Website

Azithromycin treatment follow-up: antibacterial susceptibility ofChlamydia trachomatisin patients with chronic prostatitis

Authors
Journal
International Journal of Antimicrobial Agents
0924-8579
Publisher
Elsevier
Publication Date
Volume
23
Identifiers
DOI: 10.1016/j.ijantimicag.2003.09.001
Keywords
  • Chlamydia Trachomatis
  • Azithromycin
  • Chronic Prostatitis
  • Persistence

Abstract

Abstract The antibacterial susceptibility of Chlamydia trachomatis in 138 patients with chronic prostatitis (CP) and clinical failures after antibacterial treatment with azithromycin (AZI) were investigated. Azithromycin was not found to be top-of-the-line drug in the follow-up treatment, showing only average results in vitro. The investigation of the susceptibility of chlamydia to antibiotics in causes of chronic prostatitis is highly recommended.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Azithromycin treatment follow-up: antibacterial su...

on International Journal of Antim... March 2004

Diagnosis and follow-up ofChlamydia trachomatisinf...

on The American Journal of Emerge... Jan 01, 1998

A randomized controlled trial comparing amoxicilli...

on American Journal of Obstetrics... Jan 01, 2001

Azithromycin: 4.5- or 6.0-gram dose in the treatme...

on Journal of chemotherapy (Flore... August 2004
More articles like this..